5-(4-bromo-1H-pyrazol-1-yl)-1H-tetrazole, 95.0%, 250mg

(1-AZETIDIN-3-YL-CYCLOPROPYL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

(R)-5-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95%, 250mg

Hybridisation vial Non-coated, Height, 100 mm, 35 mm, 1 Piece

6-chloro-4H,7H-thieno[2,3-b]pyridin-4-one, 95%, 500mg

Methyl 4-methoxythiophene-3-carboxylate, 95.0%, 5g

2,6-Dichloro-4-(chloromethyl)pyridine, 97.0%, 1g

(S)-2-Bromo-3-phenylpropionic acid, 95.0%, 5g

(2S,4S)-Pentane-2,4-diol, 95.0%, 25g

2-Nitronaphthalen-1-ol>98.0%(GC)(T)5g

3-Amino-[1,1'-biphenyl]-4-ol, 95.0%, 5g

(9E,12E)-OCTADECA-9,12-DIENOIC ACID, 98%, 1g

5,6-Dimethoxynicotinonitrile, 95%, 100mg